Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 3.030
- +0.110+3.77%
Close Feb 28 16:00 ET
- 3.030
- 0.0000.00%
Post 16:16 ET
193.33MMarket Cap-2.63P/E (TTM)
3.030High2.860Low365.28KVolume2.880Open2.920Pre Close1.09MTurnover1.17%Turnover RatioLossP/E (Static)63.81MShares11.97052wk High0.97P/B94.31MFloat Cap2.86052wk Low--Dividend TTM31.13MShs Float664.320Historical High--Div YieldTTM5.82%Amplitude1.530Historical Low2.975Avg Price1Lot Size
Larimar Therapeutics News
Larimar Therapeutics | SCHEDULE 13G: Others
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BEN-MAIMON CAROLE
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clayton Russell
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shankar Gopi
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Celano Michael
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | SCHEDULE 13G/A: Others
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Owl Capital Holdings LP(6.53%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(8.7%),Janus Henderson Biotech Innovation Master Fund Ltd(7.5%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Verition Fund Management LLC(0.9%),Nicholas Maounis(0.9%)
Larimar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(7.0 %),GOLDMAN SACHS & CO. LLC(7.0 %)
Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report
Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report
Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
Larimar Therapeutics | 8-K: Current report
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flynn James E
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.